This is the first commercially available test in Canada combining identification and therapeutic guidance information to support Resistance Guided Therapy for management of Mycoplasma genitalium (Mgen). Current Canadian management guidelines...
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Designation for ResistancePlus® GC - expediting the path towards clearance. This is the first commercially available molecular test that can...
PlexPCR® RespiVirus received clearance from the Australian Therapeutic Goods Administration (TGA), bringing much needed workflow advantages in time for the busy 2019 flu season. The test utilises market-leading multiplex technology...
SpeeDx have successfully started their U.S. journey by joining the Texas Health CoLab in Austin Texas. Chosen for its synergy in supporting progressive and innovative health solutions, the technology hub...
ResistancePlus® GC received clearance from the Australian Therapeutic Goods Administration (TGA) today. Launched in December with CE-IVD mark for sale in Europe, Australian laboratories can now access this world-first diagnostic...
SpeeDx announced submission of the PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA), with anticipated clearance in time for the Australian 2019 flu season. The test utilises market-leading PlexPCR®...
An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment for patients. The new test can detect patients with strains...
Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible for patients with gonorrhoea to be treated with the cheap...
The British Association for Sexual Health and HIV (BASHH) have published new guidelines for the management of gonorrhoea infections with a strong focus on antimicrobial stewardship of last-line antibiotics. The...
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually transmitted infection (STI) N. gonorrhoeae, and sequences in the gyrA...